vTv Therapeutics Inc. announced the appointment of Steven Tuch as Chief Financial Officer, effective immediately. Mr. Tuch has had a distinguished career with more than 20 years of financial and business development experience with multiple life science companies through various stages of financial planning and development. Prior to joining vTv, he served as Head of Corporate Development at Rallybio Corporation, leading the Company through its $92.7 million IPO in July 2021.

Before joining Rallybio, he held several leadership roles at BMO Capital Markets including over seven years as Managing Director, Head of Healthcare Equity Capital Markets, and completed more than 140 transactions, raising over $20 billion. Prior to BMO, Mr. Tuch held the position of Managing Director, Head of Healthcare Equity Capital Markets of Deutsche Bank Securities as well as Head of Consumer and Business Services Equity Capital Markets and Head of Private Placements, where he established the firm's private equity placement. Prior to that role, he served as Head of Private Placement Group of Thomas Weisel Partners (now Stifel) for six years managing the firm's structured equity products activity, including private equity placements, unregistered common stock PIPEs, registered directs and private converts.

Mr. Tuch earned an MBA from Stanford University's Graduate School of Business and a BBA from the University of Michigan.